Alkem Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 2,992.16 | 2,606.20 | 2,449.16 |
| Operating Expense | 2,144.33 | 1,879.47 | 1,970.37 |
| Net Profit | 697.58 | 583.25 | 324.97 |
| Net Profit Margin | 23.31 | 22.38 | 13.27 |
| Earning Per Share | 58.34 | 48.78 | 27.18 |
| EBIDTA | 910.06 | 780.30 | 492.16 |
| Effective Tax Rate | 15.61 | 15.31 | 16.17 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 2992.16 |
| Operating Expense | 2144.33 |
| Net Profit | 697.58 |
| Net Profit Margin | 23.31 |
| Earning Per Share | 58.34 |
| EBIDTA | 910.06 |
| Effective Tax Rate | 15.61 |
Invest in Alkem Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 9,747.72 | 9,054.55 | 8,829.81 |
| Operating Expenses Annual | 7,782.59 | 7,677.60 | 7,019.45 |
| Operating Profit Annual | 2,207.29 | 1,643.24 | 2,010.25 |
| Interest Annual | 81.91 | 86.40 | 37.90 |
| Depreciation | 217.71 | 204.51 | 218.98 |
| Net Profit Annual | 1,747.15 | 1,134.47 | 1,541.25 |
| Tax Annual | 133.88 | 192.52 | 212.12 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 9,747.72 |
| Operating Expenses Annual | 7,782.59 |
| Operating Profit Annual | 2,207.29 |
| Interest Annual | 81.91 |
| Depreciation | 217.71 |
| Net Profit Annual | 1,747.15 |
| Tax Annual | 133.88 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.01 | 81.82 | 15.22 |
| Cash Flow from Operations | 1,686.56 | 1,437.42 | 1,299.34 |
| Cash Flow from Investing | -865.60 | 197.04 | -1,669.33 |
| Cash Flow from Financing | -959.04 | -1,711.27 | 436.59 |
| Cash Flow at the End | -133.07 | 5.01 | 81.82 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 5.01 |
| Cash Flow from Operations | 1,686.56 |
| Cash Flow from Investing | -865.60 |
| Cash Flow from Financing | -959.04 |
| Cash Flow at the End | -133.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 22.64 | 18.15 | 22.77 |
| PBIT Margin (%) | 20.14 | 15.61 | 20.29 |
| PBT Margin (%) | 19.89 | 15.43 | 19.75 |
| Net PROFIT Margin (%) | 17.92 | 12.53 | 17.46 |
| Return On Networth / Equity (%) | 17.56 | 12.54 | 18.83 |
| Return On Networth /Employed (%) | 17.28 | 12.78 | 17.47 |
| Return On Assets (%) | 15.41 | 10.27 | 15.01 |
| Total Debt / Equity (X) | 0.11 | 0.19 | 0.22 |
| Asset Turnover Ratio (%) | 0.86 | 0.82 | 0.86 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 22.64 |
| PBIT Margin (%) | 20.14 |
| PBT Margin (%) | 19.89 |
| Net PROFIT Margin (%) | 17.92 |
| Return On Networth / Equity (%) | 17.56 |
| Return On Networth /Employed (%) | 17.28 |
| Return On Assets (%) | 15.41 |
| Total Debt / Equity (X) | 0.11 |
| Asset Turnover Ratio (%) | 0.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,823.09 | 1,868.74 | 1,882.07 |
| Total Current Assets Annual | 8,040.08 | 6,772.21 | 6,860.61 |
| Non Current Assets Annual | 5,997.72 | 5,959.01 | 6,308.56 |
| Total Shareholders Funds Annual | 10,554.61 | 9,349.85 | 8,743.66 |
| Total Assets Annual | 14,037.80 | 12,731.22 | 13,169.17 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,823.09 |
| Total Current Assets Annual | 8,040.08 |
| Non Current Assets Annual | 5,997.72 |
| Total Shareholders Funds Annual | 10,554.61 |
| Total Assets Annual | 14,037.80 |
EPS (INR)
Expected
57.60
Reported
57.60
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by -0.04%
